Search Results

CSL Behring provides protein-based and recombinant therapies for bleeding disorders, immune deficiencies, hereditary angioedema and Alpha 1 antitrypsin deficiency, among others.

https://www.cslbehring.com/products/global-products-list

CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.

https://www.cslbehring.com/products

CSL Behring is committed to advancing scientific knowledge, fostering excellence, and supporting future medical researchers.

https://www.cslbehring.com/r-and-d/awards-and-grants/material-transfers

CSL Behring is a global biotech leader in the development of new therapies for serious and rare disease.

https://www.cslbehring.com/r-and-d/product-pipeline

CSL Behring is the source for all of your fibrinogen and thrombin further manufacturing needs.

https://www.cslbehring.com/contact/thrombin-fibrinogen-inquiries

CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.

https://www.cslbehring.com/products/patents

CSL Behring's only US manufacturing plant is located in Kankakee, Illinois and employs more than 1,400 people.

https://www.cslbehring.com/our-company/kankakee-manufacturing-site

CSL Behring is committed to advancing scientific knowledge, fostering excellence, and supporting future medical researchers.

https://www.cslbehring.com/r-and-d/awards-and-grants/investigator-initiated-studies

Social Media Community Guidelines for CSL Behring Corporate Channels

https://www.cslbehring.com/social-guidelines

CSL Behring has therapies for treating ITP, an autoimmune disorder resulting in a low platelet count and susceptibility to bleeding.

https://www.cslbehring.com/patients/find-your-disease/immunodeficiency-and-autoimmune-diseases/idiopathic-thrombocytopenic-purpura